Candriam S.C.A. Purchases 72,175 Shares of Colgate-Palmolive (NYSE:CL)

Candriam S.C.A. raised its stake in Colgate-Palmolive (NYSE:CLFree Report) by 26.0% during the 4th quarter, Holdings Channel reports. The fund owned 349,673 shares of the company’s stock after acquiring an additional 72,175 shares during the period. Candriam S.C.A.’s holdings in Colgate-Palmolive were worth $31,789,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently bought and sold shares of CL. Swedbank AB raised its holdings in Colgate-Palmolive by 1.4% in the 3rd quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock valued at $306,246,000 after acquiring an additional 40,324 shares during the period. QRG Capital Management Inc. raised its holdings in Colgate-Palmolive by 12.3% in the 3rd quarter. QRG Capital Management Inc. now owns 64,342 shares of the company’s stock valued at $6,679,000 after acquiring an additional 7,067 shares during the period. FSM Wealth Advisors LLC acquired a new position in shares of Colgate-Palmolive during the 3rd quarter worth approximately $204,000. Crestwood Advisors Group LLC grew its position in shares of Colgate-Palmolive by 1.2% during the 3rd quarter. Crestwood Advisors Group LLC now owns 34,176 shares of the company’s stock worth $3,548,000 after purchasing an additional 407 shares in the last quarter. Finally, Long Run Wealth Advisors LLC acquired a new position in shares of Colgate-Palmolive during the 3rd quarter worth approximately $207,000. 80.41% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

CL has been the topic of a number of analyst reports. Morgan Stanley decreased their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. TD Cowen reduced their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Piper Sandler reduced their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. UBS Group reduced their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday, February 3rd. Finally, JPMorgan Chase & Co. cut their target price on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $101.61.

View Our Latest Analysis on Colgate-Palmolive

Colgate-Palmolive Trading Up 0.9 %

NYSE:CL opened at $91.87 on Thursday. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The stock has a market capitalization of $74.56 billion, a price-to-earnings ratio of 26.10, a PEG ratio of 4.20 and a beta of 0.44. The firm has a fifty day simple moving average of $88.72 and a two-hundred day simple moving average of $95.27. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the company earned $0.87 earnings per share. Analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.18%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.